Clinical Trials Logo

Acne Vulgaris clinical trials

View clinical trials related to Acne Vulgaris.

Filter by:

NCT ID: NCT05089708 Completed - Acne Vulgaris Clinical Trials

AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation

LEAP
Start date: December 22, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Trifarotene 50 microgram per gram (mcg/g) cream compared to its vehicle cream in the treatment of moderate acne vulgaris with risk of acne-induced post inflammatory hyperpigmentation (PIH) after 24 weeks of treatment in facial acne participants

NCT ID: NCT05080764 Recruiting - Acne Vulgaris Clinical Trials

Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults

Start date: December 10, 2021
Phase: Phase 2
Study type: Interventional

The aim of this study is to test the safety and efficacy of photodynamic therapy (PDT) for the medication Ameluz® performed with the PDT-lamp BF-RhodoLED® in comparison to the respective placebo treatment for moderate to severe Acne vulgaris.

NCT ID: NCT05071274 Completed - Acne Vulgaris Clinical Trials

A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Microneedling With SkinPen in Female and Male Subjects With Facial Acne Vulgaris, Ages 18 Through 45

Start date: March 15, 2021
Phase: N/A
Study type: Interventional

This single-center, proof of concept trial is being conducted over the course of 42 days followed by a 2-month post-last treatment visit in order to assess the efficacy and tolerability of the Sponsor's SkinPen device in treating Acne Vulgaris on the face.

NCT ID: NCT05069272 Recruiting - Acne Vulgaris Clinical Trials

Double-blinded, Vehicle Controlled Study to Evaluate Efficacy & Tolerance of Bakuchiol and Ethyl Linoleate on Acne

Start date: September 10, 2021
Phase: N/A
Study type: Interventional

Subjects will be assigned to a active cream or vehicle to compare the cosmetic effects. This will take place over a 12 week period.

NCT ID: NCT05061615 Not yet recruiting - Acne Vulgaris Clinical Trials

Clinico-demographic Features of Patients With Acne Vulgaris

Start date: October 1, 2021
Phase:
Study type: Observational

The Global Burden of Disease Study 2010 found that acne vulgaris is the eight most common skin disease, with an estimated global prevalence (for all ages) of 9.38%.(1) Furthermore . Acne is a chronic inflammatory process that presents with two types of lesions clinically; non-inflammatory (closed and open) and inflammatory lesions (papules ,pustules ,nodules and post inflammatory pigmentary changes).

NCT ID: NCT05035979 Not yet recruiting - Acne Vulgaris Clinical Trials

Oral Baidi Quzhi Granule Combined With Ju Ying Cream for Acne Vulgaris

Start date: December 1, 2021
Phase: Phase 3
Study type: Interventional

We designed the study as a double-blind,randomized,controlled clinical trial.The aim of this trial is to clarify the treatment efficacy, safety, and recurrence control of BaiDi QuZhi(BDQZ) granule combined with Ju Yin(JY) cream in the treatment of acne vulgaris.

NCT ID: NCT05012735 Completed - Acne Vulgaris Clinical Trials

A Study of a Hydrocolloid Bandage on Pimples

Start date: July 19, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and tolerability of a hydrocolloid bandage on pimples when used overnight for one week.

NCT ID: NCT05010538 Completed - Acne Vulgaris Clinical Trials

Sarecycline Truncal Acne Safety and Efficacy Response

TASER
Start date: March 9, 2021
Phase:
Study type: Observational

The purpose of this study is to determine the efficacy and safety of oral sarecycline 1.5 mg/kg/day in truncal acne. Patients with moderate to severe acne vulgaris will be observed over a period of 12 weeks. Lesion counts, investigator's global assessments, photography, and safety measures will be assessed for the trunk and face.

NCT ID: NCT04975412 Completed - Acne Vulgaris Clinical Trials

Relationship of Whole Blood Zinc Levels to Acne Severity

Start date: November 27, 2017
Phase:
Study type: Observational

Acne Vulgaris is one of the most common dermatologic diagnoses in the world. A number of studies have been conducted comparing serum zinc levels with acne vulgaris; however, no studies have yet been done in the Philippine setting. The objective of this study is to determine the relationship between whole blood zinc levels and the severity of acne vulgaris in Filipino patients and normal controls who are 18-25 years old.

NCT ID: NCT04960930 Completed - Acne Vulgaris Clinical Trials

To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris

Start date: September 17, 2021
Phase: Phase 3
Study type: Interventional

This is a randomized, multicenter, double-blind, vehicle-controlled, 2-arm study to evaluate the safety and efficacy in 12 weeks of FMX101 minocycline foam, 4%, compared to vehicle, in the treatment of subjects with moderate to severe facial acne vulgaris.